UBMT17083 / STUDY00001522 / Omar AljitawiResearch Question:
What is the effect of one hyperbaric oxygen therapy session prior to hematopoetic
stem cell infusion compared to no hyperbaric oxygen therapy session before hematopoetic
stem cell infusion?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
Patients with Multiple Myeloma who are considered for high-dose therapy and autologous
transplantation at the bone marrow transplant clinic at the Wilmot Cancer Institute
(WCI) will be be approached to participate in this trial. Eligible patients who choose
to participate will be randomized so that half receive one hyperbaric oxygen therapy
session prior to hematopoetic stem cell infusion and half will not. All subjects will
have their blood counts monitored closely and time to count recovery will be compared
between the two groups.
Study Reference #: UBMT17083-
Lead Researcher (Principal Investigator)
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search